Login / Signup

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives.

Ramon Andrade Bezerra De MelloNathália Moisés NevesHakaru TadokoroGiovanna Araújo AmaralPedro Castelo-BrancoVictor André de Almeida Zia
Published in: Journal of clinical medicine (2020)
Challenges in NSCLC treatment include resistance to 3rd generation TKIs, the high cost of ALK inhibitors, and the need for further research on new drugs.
Keyphrases
  • advanced non small cell lung cancer
  • epidermal growth factor receptor
  • small cell lung cancer
  • tyrosine kinase
  • combination therapy
  • replacement therapy
  • brain metastases